Reata reinforces management team
This article was originally published in Scrip
Executive Summary
Reata Pharmaceuticals has expanded its management team with the appointment of four executives: Dr Paul Audhya, who has previously led drug development at Johnson & Johnson, Bristol-Myers Squibb and Abbott Laboratories, joins as vice-president of development and chief medical officer; Dr Hilary Malone joins as vice-president and chief regulatory and compliance officer from Pfizer, where she was senior vice-president and head of worldwide regulatory strategy; Sean Nolan, who joins Reata as vice-president and chief commercial officer, was previously president of the US entity that emerged following Lundbeck's acquisition of Ovation Pharmaceuticals; and Jim Rouse, most recently executive director of information technology at PharmaNet Development Group, joins as chief information officer. In addition, the company has elected Nancy Wysenski, executive vice-president and chief commercial officer of Vertex Pharmaceuticals, to its board of directors.